Migraine Minute News Update

Association of Migraine Disorders
  • 5.0 (3)
  • HEALTH & FITNESS
  • UPDATED MONTHLY
Migraine Minute News Update Podcast

The Migraine Minute provides weekly updates in migraine research and news hosted by Molly O'Brien of the Association of Migraine Disorders.

  1. SEP 6

    Are CGRP mAbs Cost Effective?

    A study found that anti-CGRP monoclonal antibodies not only reduced absenteeism & presenteeism in Spain, they were found to be cost-effective too. Read more: http://bit.ly/3S1KS5Y Image courtesy: DOI 10.1186/s10194-024-01727-0

    1 min

  2. AUG 16

    Atogepant vs. Rimegepant. New study looks at indirect comparison

    A new study looks at the efficacy and safety of two gepant medications. Molly O'Brien will share the study findings in this Migraine Minute News update.  Read the study: bit.ly/4cwJQar Image courtesy: Sage Journals. Cephalalgia doi:10.1177/03331024241235156

    1 min

  3. AUG 2

    Is there a link between photophobia and poor sleep quality?

    Light sensitivity and poor sleep quality in people with migraine, could the two be related? In a study published in the Journal of Headache and Pain, researchers looked at the impact photophobia may have on sleep quality in people with migraine. Molly O’Brien breaks it down in this Migraine Minute News Update. Learn more: bit.ly/4cIJMUD

    2 min

  4. JUL 19

    Can a caffeine habit impact episodic migraine?

    Caffeine habit? A new study looks at the link between episodic migraine and regular caffeine intake. Molly O’Brien will fill you in, in this latest Migraine Minute News Update. Learn more about the study at bit.ly/4bzLyXu

    1 min

  5. JUL 5

    FDA Clears a New TENS Device for Migraine Prevention

    The US FDA clears another wearable drug-free migraine treatment device. In this Migraine Minute News Update, Molly O’Brien will tell you all about a new TENS device available for people with episodic migraine. Read more: https://bit.ly/4aEZFe9

    1 min

  6. JUN 14

    Do CGRP Monoclonal Antibodies wear off at the end of the month?

    Many people with chronic migraine worry that their monthly preventive medication won’t work as well at the end of the month as it did at the beginning. New research shows that two injectable CGRP monoclonal antibodies do not wear off at the end of the month. Molly O’Brien has the details in this #MigraineMinute News Update.   Read more: bit.ly/3w95WQn

    1 min

  7. MAY 31

    Can This Gepant be an Effective Preventive Treatment Option for Tough to Treat Episodic Migraine?

    A study in the Lancet found one oral gepant to be safe and effective in people with episodic migraine who have failed two to four classes of preventive treatments. Molly O’Brien explains in this Migraine Minute News Update. Read the study here: https://bit.ly/3w3ZM45

    1 min

  8. MAY 17

    Comparing Anti-CGRP monoclonal antibodies to OnabotulinumtoxinA for chronic migraine

    A new study looks at real-word effectiveness of Anti-CGRP monoclonal antibodies & OnabotulinumtoxinA for chronic migraine. Molly O'Brien will share the study findings in this Migraine Minute News update. Read the study: https://bit.ly/4d1mPx1 *The graphic used in this content is courtesy of Grazzi, L., Giossi, R., Montisano, D.A. et al. Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study. J Headache Pain 25, 14 (2024). https://doi.org/10.1186/s10194-024-01721-6. The graphical abstract has been slightly modified.

    1 min
See All (86)

Ratings & Reviews

5
out of 5
3 Ratings

About

The Migraine Minute provides weekly updates in migraine research and news hosted by Molly O'Brien of the Association of Migraine Disorders.

Information

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada